Department of Neurology, Children's National Medical Center, Center for Neuroscience and Behavioral Medicine, Washington, DC 20010, USA.
Mol Genet Metab. 2010;100 Suppl 1(Suppl 1):S20-30. doi: 10.1016/j.ymgme.2010.01.017. Epub 2010 Feb 13.
Urea cycle disorders (UCD) represent a group of rare inborn errors of metabolism that carry a high risk of mortality and neurological morbidity resulting from the effects of accumulation of ammonia and other biochemical intermediates. These disorders result from single gene defects involved in the detoxification pathway of ammonia to urea. UCD include deficiencies in any of the six enzymes and two membrane transporters involved in urea biosynthesis. It has previously been reported that approximately half of infants who present with hyperammonemic coma in the newborn period die of cerebral edema; and those who survive 3days or more of coma invariably have intellectual disability [1]. In children with partial defects there is an association between the number and severity of recurrent hyperammonemic (HA) episodes (i.e. with or without coma) and subsequent cognitive and neurologic deficits [2]. However, the effects of milder or subclinical HA episodes on the brain are largely unknown. This review discusses the results of neuroimaging studies performed as part of the NIH funded Rare Diseases Clinical Research Center in Urea Cycle Disorders and focuses on biomarkers of brain injury in ornithine transcarbamylase deficiency (OTCD). We used anatomic imaging, functional magnetic resonance imaging (fMRI), diffusion-tensor imaging (DTI), and (1)H/(13)C magnetic resonance spectroscopy (MRS) to study clinically stable adults with partial OTCD. This allowed us to determine alterations in brain biochemistry associated with changes in cell volume and osmolarity and permitted us to identify brain biomarkers of HA. We found that white matter tracts underlying specific pathways involved in working memory and executive function are altered in subjects with OTCD (as measured by DTI), including those heterozygous women who were previously considered asymptomatic. An understanding of the pathogenesis of brain injury in UCD is likely to advance our knowledge of more common disorders of liver dysfunction.
尿素循环障碍(UCD)代表一组罕见的先天性代谢错误,由于氨和其他生化中间产物的积累,这些疾病会导致高死亡率和神经发育障碍。这些疾病是由于参与氨到尿素解毒途径的单个基因突变引起的。UCD 包括参与尿素合成的六种酶和两种膜转运体中的任何一种缺陷。先前有报道称,大约一半在新生儿期出现高氨血症昏迷的婴儿死于脑水肿;而那些昏迷超过 3 天或以上的婴儿无一例外地患有智力残疾[1]。在部分缺陷的儿童中,反复发生高氨血症(HA)发作(即伴有或不伴有昏迷)的次数和严重程度与随后的认知和神经功能缺陷之间存在关联[2]。然而,轻度或亚临床 HA 发作对大脑的影响在很大程度上尚不清楚。这篇综述讨论了 NIH 资助的尿素循环障碍罕见疾病临床研究中心进行的神经影像学研究的结果,并重点介绍了瓜氨酸血症(OTCD)的脑损伤生物标志物。我们使用解剖成像、功能磁共振成像(fMRI)、弥散张量成像(DTI)和(1)H/(13)C 磁共振波谱(MRS)来研究患有部分 OTCD 的临床稳定成年人。这使我们能够确定与细胞体积和渗透压变化相关的脑生化变化,并使我们能够确定 HA 的脑生物标志物。我们发现,与工作记忆和执行功能相关的特定途径的白质束在 OTCD 患者中发生改变(通过 DTI 测量),包括那些以前被认为无症状的杂合子女性。对 UCD 中脑损伤发病机制的了解可能会增进我们对更常见的肝功能障碍疾病的认识。